BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 2670487)

  • 41. The effect of terminal ileal triglyceride infusion on gastroduodenal motility and the intragastric distribution of a solid meal.
    Fone DR; Horowitz M; Read NW; Dent J; Maddox A
    Gastroenterology; 1990 Mar; 98(3):568-75. PubMed ID: 2298363
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Effect of EM574 on postprandial pancreaticobiliary secretion, gastric motor activity, and emptying in conscious dogs.
    Tanaka T; Mizumoto A; Mochiki E; Suzuki H; Itoh Z; Omura S
    Dig Dis Sci; 1999 Jun; 44(6):1100-6. PubMed ID: 10389679
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Peripheral oxyntomodulin reduces food intake and body weight gain in rats.
    Dakin CL; Small CJ; Batterham RL; Neary NM; Cohen MA; Patterson M; Ghatei MA; Bloom SR
    Endocrinology; 2004 Jun; 145(6):2687-95. PubMed ID: 15001546
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effect of Oxyntomodulin, Glucagon, GLP-1, and Combined Glucagon +GLP-1 Infusion on Food Intake, Appetite, and Resting Energy Expenditure.
    Bagger JI; Holst JJ; Hartmann B; Andersen B; Knop FK; Vilsbøll T
    J Clin Endocrinol Metab; 2015 Dec; 100(12):4541-52. PubMed ID: 26445112
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Enteroglucagon.
    Holst JJ
    Annu Rev Physiol; 1997; 59():257-71. PubMed ID: 9074764
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Somatostatin enhances the inhibitory effect of oxyntomodulin and its C-terminal octapeptide on acid secretion.
    Dubrasquet JM; Audousset-Puech MP; Martinez J; Bataille D
    Peptides; 1986; 7 Suppl 1():257-9. PubMed ID: 2875447
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Effect of ethanol ingestion on postprandial gastric emptying and secretion, biliopancreatic secretions, and duodenal absorption in man.
    Jian R; Cortot A; Ducrot F; Jobin G; Chayvialle JA; Modigliani R
    Dig Dis Sci; 1986 Jun; 31(6):604-14. PubMed ID: 3709325
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Demonstration of a specific receptor site for glucagon-37 (oxyntomodulin/bioactive enteroglucagon) in rat oxyntic glands].
    Depigny C; Lupo B; Kervran A; Bataille D
    C R Acad Sci III; 1984; 299(16):677-80. PubMed ID: 6097350
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The glucagon-like peptide-1 receptor agonist oxyntomodulin enhances beta-cell function but does not inhibit gastric emptying in mice.
    Maida A; Lovshin JA; Baggio LL; Drucker DJ
    Endocrinology; 2008 Nov; 149(11):5670-8. PubMed ID: 18669601
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Relation between fasting antroduodenal motility and transpyloric fluid movements.
    Schindlbeck NE; Heinrich C; Müller-Lissner SA
    Am J Physiol; 1989 Aug; 257(2 Pt 1):G198-201. PubMed ID: 2764107
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A role for pancreatic polypeptide in the regulation of gastric emptying and short-term metabolic control.
    Schmidt PT; Näslund E; Grybäck P; Jacobsson H; Holst JJ; Hilsted L; Hellström PM
    J Clin Endocrinol Metab; 2005 Sep; 90(9):5241-6. PubMed ID: 15998783
    [TBL] [Abstract][Full Text] [Related]  

  • 52. N-acetyl oxyntomodulin30-37: pharmacokinetics and activity on gastric acid secretion.
    Carles-Bonnet C; Jarrousse C; Niel H; Martinez J; Rolland M; Bataille D
    Naunyn Schmiedebergs Arch Pharmacol; 1992 Jan; 345(1):57-63. PubMed ID: 1538791
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Short-term inhibition of duodenal tryptic activity does not affect human pancreatic, biliary, or gastric function.
    Hotz J; Ho SB; Go VL; DiMagno EP
    J Lab Clin Med; 1983 Mar; 101(3):488-95. PubMed ID: 6186758
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Radionuclide studies on gastric evacuatory function in health and in the duodenal ulcer disease. I. Types of solid meal distribution within the stomach and their relation to gastric emptying.
    Jonderko K
    Nucl Med Commun; 1987 Aug; 8(8):671-80. PubMed ID: 3320833
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Intraileal carbohydrate regulates canine postprandial pancreaticobiliary secretion and upper gut motility.
    Tohno H; Sarr MG; DiMagno EP
    Gastroenterology; 1995 Dec; 109(6):1977-85. PubMed ID: 7498664
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Glucagon-like peptide 1 inhibition of gastric emptying outweighs its insulinotropic effects in healthy humans.
    Nauck MA; Niedereichholz U; Ettler R; Holst JJ; Orskov C; Ritzel R; Schmiegel WH
    Am J Physiol; 1997 Nov; 273(5):E981-8. PubMed ID: 9374685
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Colonic fermentation and proximal gastric tone in humans.
    Ropert A; Cherbut C; Rozé C; Le Quellec A; Holst JJ; Fu-Cheng X; Bruley des Varannes S; Galmiche JP
    Gastroenterology; 1996 Aug; 111(2):289-96. PubMed ID: 8690193
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Erythromycin antagonizes the deceleration of gastric emptying by glucagon-like peptide 1 and unmasks its insulinotropic effect in healthy subjects.
    Meier JJ; Kemmeries G; Holst JJ; Nauck MA
    Diabetes; 2005 Jul; 54(7):2212-8. PubMed ID: 15983224
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Ileal release of glucagon-like peptide-1 (GLP-1). Association with inhibition of gastric acid secretion in humans.
    Layer P; Holst JJ; Grandt D; Goebell H
    Dig Dis Sci; 1995 May; 40(5):1074-82. PubMed ID: 7729267
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Peptic ulcer and intestinal hormones].
    Geller LI
    Klin Med (Mosk); 1986 Apr; 64(4):32-7. PubMed ID: 2873268
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.